logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Kathrin Heinrich

university of munich
H指数:20
被引数:2,689

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gastric and rectal administration of encorafenib with targeted chemotherapy against BRAF V600E-mutant rectal cancer with bowel obstruction

针对BRAF V600E突变型伴有肠梗阻的直肠癌，采用Encorafenib靶向化疗联合胃和直肠给药

Oncologist
IF4.2
2026-05-010
PRE
Funk, Maximilian Alexander; Heinemann, Volker; Bucklein, Veit; Alig, Stefan Karl; Heinrich, Kathrin; Weiss, Lena; Krenmayr, Victoria; Blanchet, Benoit; Kunz, Wolfgang Gerhard; Theurich, Sebastian; von Bergwelt-Baildon, Michael; Holch, Julian Walter
Impact of Sex on Efficacy and Safety of 1st-Line Treatment with FOLFIRI plus Cetuximab or Bevacizumab in RAS/BRAF Wildtype Metastatic Colorectal Cancer– A subgroup analysis of the FIRE-3 (AIO KRK-0306) Trial

性別对FOLFIRI联合西妥昔单抗或贝伐珠单抗作为RAS/BRAF野生型转移性结直肠癌一线治疗方案有效性和安全性的影响——FIRE-3 (AIO KRK-0306)试验的亚组分析

European Journal of Cancer
IF7.1
2025-11-220
PRE
Kathrin Heinrich; Sebastian Stintzing; Ludwig Fischer von Weikersthal; Thomas Decker; Alexander Kiani; Florian Kaiser; Salah-Eddin Al-Batran; Tobias Heintges; Christoph Lerchenmüller; Christoph Kahl; Gernot Seipelt; Frank Kullmann; Markus Moehler; Werner Scheithauer; Andreas Jung; Julian W. Holch; Swantje Held; Dominik Paul Modest; Volker Heinemann
First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAFV600E-mutated metastatic colorectal cancer according to primary tumor sidedness: a pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)

抗EGFR抗体与抗VEGF抗体在BRAFV600E突变型转移性结直肠癌中根据原发肿瘤侧性的初始治疗疗效：一项在mCRC初始治疗中进行的七项临床试验的合并分析（德国AIO研究组）

European Journal of Cancer
IF7.1
2025-11-130
OAAI
Lena Weiss; Sebastian Stintzing; Dominik Paul Modest; Arndt Stahler; Ludwig Fischer von Weikersthal; Anke Reinacher-Schick; Thomas Decker; Victoria Probst; Kathrin Heinrich; Ingo Schwaner; Florian Kaiser; Rudolf Pihusch; Martin Fuchs; Swantje Held; Annabel Alig; Birgit Gruenberger; Gerald Werner Prager; David Tougeron; Julien Taieb; Volker Heinemann
Correction: Precision Oncology in Rare Endocrine and Neuroendocrine Neoplasms: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board

更正：精准肿瘤学在罕见内分泌和神经内分泌新生物中的应用：CCCMunichLMU分子肿瘤委员会的经验与挑战

Targeted Oncology
IF4
2025-08-270
OAAI
Klara Dorman; Christoph J. Auernhammer; Christine Spitzweg; Ralf Schmidmaier; Svenja Nölting; Matthias Kroiss; Martin Reincke; Christian Schulz; Martin Angele; Jens Werner; Christine Schmid-Tannwald; Josefine Rauch; Mathias Zacherl; Thomas Knösel; Jörg Kumbrink; Andreas Jung; Frederick Klauschen; Amanda Tufman; Danmei Zhang; Lena Weiss; Stefan Boeck; Michael von Bergwelt-Baildon; Volker Heinemann; C. Benedikt Westphalen; Kathrin Heinrich
Risk of disease progression in the first-line therapy of metastatic colorectal cancer to guide disease re-assessments - analysis of eleven trials by AIO and GONO

转移性结直肠癌一线治疗中疾病进展的风险，以指导疾病再评估——AIO和GONO对11项试验的分析

Annals of Oncology
IF65.4
2025-08-190
OAAI
M.M. Germani; V. Heinemann; D. Rossini; L. Fischer von Weikersthal; F. Pietrantonio; K. Heinrich; A. Stahler; S. Lonardi; F. Kaiser; T. Decker; L. Salvatore; L. Weiss; F. Morano; M. Fuchs; F. Bergamo; C. Antoniotti; G. Masi; S. Stintzing; P. Frumento; C. Cremolini; D.P. Modest
Outcomes for FOLFIRI plus bevacizumab or cetuximab in patients treated with oxaliplatin-based adjuvant therapy: a combined analysis of FIRE-3 and CALGB/SWOG 80405 (Alliance)

FOLFIRI联合贝伐珠单抗或西妥昔单抗在奥沙利铂为基础辅助治疗患者中的疗效：FIRE-3和CALGB/SWOG 80405 (Alliance)联合分析

European Journal of Cancer
IF7.1
2025-08-050
PRE
Francesca Battaglin; Bert H O'Neil; Sebastian Stintzing; Fang-Shu Ou; Tyler J Zemla; Donna Niedzwiecki; Federico Innocenti; Howard S Hochster; Ludwig Fischer von Weikersthal; Thomas Decker; Alexander Kiani; Ursula Vehling-Kaiser; Tobias Heintges; Christian Lerchenmüller; Lena Weiss; Kathrin Heinrich; Richard M Goldberg; Robert J Mayer; Richard L Schilsky; Charles D Blanke; Alan P Venook; Heinz-Josef Lenz; Volker Heinemann
Precision Oncology in Rare Endocrine and Neuroendocrine Neoplasms: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board

罕见内分泌及神经内分泌新生物的精准肿瘤学：CCCMunichLMU分子肿瘤委员会的经验与挑战

Targeted Oncology
IF4
2025-06-300
OAAI
Klara Dorman; Christoph J. Auernhammer; Christine Spitzweg; Ralf Schmidmaier; Svenja Nölting; Matthias Kroiss; Martin Reincke; Christian Schulz; Martin Angele; Jens Werner; Christine Schmid-Tannwald; Josefine Rauch; Mathias Zacherl; Thomas Knösel; Jörg Kumbrink; Andreas Jung; Frederick Klauschen; Amanda Tufman; Danmei Zhang; Lena Weiss; Stefan Böck; Michael von Bergwelt-Baildon; Volker Heinemann; C. Benedikt Westphalen; Kathrin Heinrich
Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer-results from the FIRE-4.5 study
MOLECULAR ONCOLOGY
IF4.5
2024-12-040
PRE
Klein-Scory, Susanne; Baraniskin, Alexander; Schmiegel, Wolff; Mika, Thomas; Schroers, Roland; Held, Swantje; Heinrich, Kathrin; Tougeron, David; Modest, Dominik P.; Schwaner, Ingo; Eucker, Jan; Pihusch, Rudolf; Stauch, Martina; Kaiser, Florian; Kahl, Christoph; Karthaus, Meinolf; Mueller, Christian; Burkart, Christof; Stintzing, Sebastian; Heinemann, Volker
Evaluation of risk of disease progression in first-line therapy of unresected metastatic colorectal cancer to guide intervals of radiological assessment: An analysis of eleven randomized trials by AIO and GONO

评估不可切除的转移性结直肠癌一线治疗中疾病进展风险的评估，以指导放射学评估的间隔：AIO和GONO进行的十一项随机试验的分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Germani, M. M.; Heinemann, V.; Rossini, D.; von Weikersthal, L. Fischer; Morano, F.; Heinrich, K.; Stahler, A.; Bergamo, F.; Kaiser, F.; Decker, T.; Salvatore, L.; Weiss, L.; Russo, A.; Fuchs, M.; Prete, A. A.; Antoniotti, C.; Masi, G.; Stintzing, S.; Cremolini, C.; Modest, D. P.
FIRE-6: Longitudinal immune profiling identified disturbed NK cell functionality in RAS/BRAF wild-type metastatic colorectal cancer patients and during combined treatment with FOLFIRI, cetuximab followed by avelumab maintenance

FIRE-6：纵向免疫谱分析鉴定了RAS/BRAF野生型转移性结直肠癌患者中NK细胞功能紊乱的情况，并在接受FOLFIRI、西妥昔单抗联合阿维单抗维持治疗期间观察到这种现象。

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Schiele, P.; Kolling, S.; Stintzing, S.; Junkuhn, C.; Walter, A.; Rosnev, S.; von Einem, J.; Schoening, W.; Sauer, I.; Modest, D. P.; Heinrich, K.; Weiss, L.; Bullinger, L.; Frentsch, M.; Heinemann, V.; Na, I-K
Impact of primary tumor sidedness and sex on prognosis and anti-epidermal growth factor receptor antibody efficacy in BRAF-mutant metastatic colorectal cancer: a pooled analysis of AIO studies FIRE-1, CIOX, FIRE-3, XELAVIRI, and VOLFI
ESMO OPEN
IF8.3
2024-09-010
OAAI
Alig, A. H. S.; Modest, D. P.; Stintzing, S.; Heinrich, K.; Geissler, M.; von Weikersthal, L. Fischer; Decker, T.; Vehling-Kaiser, U.; Held, S.; Moosmann, N.; Stahler, A.; Tannapfel, A.; Giessen-Jung, C.; Jung, A.; Weiss, L.; Heinemann, V.
Dermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX D Pmab induction: a prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trial
ESMO OPEN
IF8.3
2024-07-010
OAAI
Ballhausen, A.; Karthaus, M.; Fruehauf, S.; Graeven, U.; Mueller, L.; Koenig, A. O.; von Weikersthal, L. F.; Sommerhaeuser, G.; Jelas, I.; Alig, A. H. S.; Kurreck, A.; Stahler, A.; Goekkurt, E.; Held, S.; Kasper, S.; Heinrich, K.; Heinemann, V.; Stintzing, S.; Trarbach, T.; Modest, D. P.
Relevance of local treatment with curative intent (LT) against metastatic colorectal cancer (mCRC): Findings of a retrospective cohort study at the Comprehensive Cancer Center Munich (CCC MunichLMU)
ANNALS OF ONCOLOGY
IF65.4
2024-06-010
PRE
Eisenburger, J-A.; Weber, A.; Wiberg, Y.; Allmendinger, F.; Wehlau, I. M. M. Kammermeier; Wagner, D.; Reischer, A.; Weiss, L.; Heinrich, K.; Westphalen, C. B.; Probst, V.; Fey, T.; Berger-Thurmel, K.; Walter, F.; Seidensticker, R.; Ricke, J.; von Bergwelt, M.; Heinemann, V.; Holch, J. W.

研究方向

暂未获取到该数据
D
Dominik Paul Modest
H 指数:44论文数:436被引数:9,216
S
Sebastian Stintzing
H 指数:49论文数:799被引数:1.1万
L
Ludwig Fischer von Weikersthal
H 指数:41论文数:292被引数:9,552
A
Arndt Stahler
H 指数:16论文数:162被引数:988
V
Volker Heinemann
H 指数:91论文数:1,250被引数:4.3万
T
Thomas Decker
H 指数:61论文数:573被引数:1.6万
S
Swantje Held
H 指数:24论文数:181被引数:2,767
L
Lena Weiss
H 指数:9论文数:60被引数:295
C
C. Benedikt Westphalen
H 指数:46论文数:297被引数:1.2万
F
Florian Kaiser
H 指数:29论文数:293被引数:4,493